Controversies in the Management of Severe ARDS: Optimal Ventilator Management and Use of Rescue Therapies

Brian O'Gara; Eddy Fan; Daniel S. Talmor

doi:10.1055/s-0035-1564889

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2015; 36(06): 823-834
DOI: 10.1055/s-0035-1564889

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Controversies in the Management of Severe ARDS: Optimal Ventilator Management and Use of Rescue Therapies

Autoren

Brian O'Gara

¹Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Eddy Fan

²Interdepartmental Division of Critical Care Medicine, Institute of Health Policy, Management and Evaluation University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada
Daniel S. Talmor

¹Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Abstract

Groundbreaking research into the pathophysiology of the adult acute respiratory distress syndrome (ARDS) and the prevention of ventilator-induced lung injury has led to dramatic improvements in survival. Investigations over the last two decades have revolved around the development of rescue therapies that can be used for patients with severe ARDS and refractory hypoxemia. To date, the techniques of using high levels of positive end-expiratory pressure (PEEP), prompt institution of neuromuscular blockade, and early prolonged prone positioning have been shown to reduce mortality in patients with severe ARDS. PEEP titration using transpulmonary pressure estimations assisted by esophageal manometry has been shown to result in a substantial improvement in oxygenation. Extracorporeal membrane oxygenation (ECMO) has been used increasingly since the mid-2000s in part due to the H1N1 epidemic. A major randomized controlled trial conducted during this period showed a significant mortality benefit for patients with severe ARDS who were referred to a center with ECMO capabilities. The routine use of inhaled nitric oxide for patients with severe ARDS has not been shown to lead to more than a transient and limited improvement in oxygenation, which may hinder its use as a sole rescue therapy. Finally, recent studies have found that the routine use of high-frequency oscillatory ventilation in severe ARDS does not result in decreased mortality, although the technique has not been specifically investigated as rescue therapy for severe refractory hypoxemia.

Keywords

acute respiratory distress syndrome - positive end-expiratory pressure - esophageal manometry - neuromuscular blockade - prone positioning - nitric oxide - extracorporeal membrane oxygenation - high-frequency oscillatory ventilation

Volltext

Referenzen

References
1 Amato MB, Barbas CS, Medeiros DM , et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338 (6) 347-354
2 The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1301-1308
3 Truwit JD, Bernard GR, Steingrub J , et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014; 370 (23) 2191-2200
4 Bernard GR, Artigas A, Brigham KL , et al; The Consensus Committee. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 1994; 20 (3) 225-232
5 Ranieri VM, Rubenfeld GD, Thompson BT , et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307 (23) 2526-2533
6 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2 (7511) 319-323
7 Gattinoni L, D'Andrea L, Pelosi P, Vitale G, Pesenti A, Fumagalli R. Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA 1993; 269 (16) 2122-2127
8 Brower RG, Lanken PN, MacIntyre N , et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351 (4) 327-336
9 Mercat A, Richard JC, Vielle B , et al; Expiratory Pressure (Express) Study Group. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299 (6) 646-655
10 Briel M, Meade M, Mercat A , et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303 (9) 865-873
11 Dasenbrook EC, Needham DM, Brower RG, Fan E. Higher PEEP in patients with acute lung injury: a systematic review and meta-analysis. Respir Care 2011; 56 (5) 568-575
12 Santa Cruz R, Rojas JI, Nervi R, Heredia R, Ciapponi A. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2013; 6: CD009098
13 Goligher EC, Kavanagh BP, Rubenfeld GD , et al. Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med 2014; 190 (1) 70-76
14 Gattinoni L, Caironi P. Refining ventilatory treatment for acute lung injury and acute respiratory distress syndrome. JAMA 2008; 299 (6) 691-693
15 Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999; 116 (1, Suppl): 9S-15S
16 Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34 (5) 1311-1318
17 Maggiore SM, Jonson B, Richard JC, Jaber S, Lemaire F, Brochard L. Alveolar derecruitment at decremental positive end-expiratory pressure levels in acute lung injury: comparison with the lower inflection point, oxygenation, and compliance. Am J Respir Crit Care Med 2001; 164 (5) 795-801
18 Jonson B, Richard JC, Straus C, Mancebo J, Lemaire F, Brochard L. Pressure-volume curves and compliance in acute lung injury: evidence of recruitment above the lower inflection point. Am J Respir Crit Care Med 1999; 159 (4, Pt 1): 1172-1178
19 Talmor D, Sarge T, O'Donnell CR , et al. Esophageal and transpulmonary pressures in acute respiratory failure. Crit Care Med 2006; 34 (5) 1389-1394
20 Talmor D, Sarge T, Malhotra A , et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 2008; 359 (20) 2095-2104
21 Ware LB. Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 2005; 33 (3, Suppl): S217-S222
22 de Chazal I, Hubmayr RD. Novel aspects of pulmonary mechanics in intensive care. Br J Anaesth 2003; 91 (1) 81-91
23 Guérin C, Richard JC. Comparison of 2 correction methods for absolute values of esophageal pressure in subjects with acute hypoxemic respiratory failure, mechanically ventilated in the ICU. Respir Care 2012; 57 (12) 2045-2051
24 Grasso S, Terragni P, Birocco A , et al. ECMO criteria for influenza A (H1N1)-associated ARDS: role of transpulmonary pressure. Intensive Care Med 2012; 38 (3) 395-403
25 Gulati G, Novero A, Loring SH, Talmor D. Pleural pressure and optimal positive end-expiratory pressure based on esophageal pressure versus chest wall elastance: incompatible results. Crit Care Med 2013; 41 (8) 1951-1957
26 Piehl MA, Brown RS. Use of extreme position changes in acute respiratory failure. Crit Care Med 1976; 4 (1) 13-14
27 Pappert D, Rossaint R, Slama K, Grüning T, Falke KJ. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest 1994; 106 (5) 1511-1516
28 Albert RK, Leasa D, Sanderson M, Robertson HT, Hlastala MP. The prone position improves arterial oxygenation and reduces shunt in oleic-acid-induced acute lung injury. Am Rev Respir Dis 1987; 135 (3) 628-633
29 Pelosi P, Tubiolo D, Mascheroni D , et al. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 1998; 157 (2) 387-393
30 Slutsky AS. The acute respiratory distress syndrome, mechanical ventilation, and the prone position. N Engl J Med 2001; 345 (8) 610-612
31 Guerin C, Gaillard S, Lemasson S , et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004; 292 (19) 2379-2387
32 Mancebo J, Fernández R, Blanch L , et al. A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 173 (11) 1233-1239
33 Taccone P, Pesenti A, Latini R , et al; Prone-Supine II Study Group. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA 2009; 302 (18) 1977-1984
34 Guérin C, Reignier J, Richard JC , et al; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368 (23) 2159-2168
35 Beitler JR, Shaefi S, Montesi SB , et al. Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: a meta-analysis. Intensive Care Med 2014; 40 (3) 332-341
36 Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA 1991; 266 (20) 2870-2875
37 Gainnier M, Roch A, Forel JM , et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32 (1) 113-119
38 Forel JM, Roch A, Marin V , et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34 (11) 2749-2757
39 Watling SM, Dasta JF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit Care Med 1994; 22 (5) 884-893
40 Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153 (5) 1686-1690
41 Papazian L, Forel JM, Gacouin A , et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363 (12) 1107-1116
42 Alhazzani W, Alshahrani M, Jaeschke R , et al. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 2013; 17 (2) R43
43 Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL , et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001; 27 (8) 1288-1296
44 Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2014; 1: CD006832
45 Fan E, Dowdy DW, Colantuoni E , et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 2014; 42 (4) 849-859
46 Zapol WM, Snider MT, Hill JD , et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242 (20) 2193-2196
47 Morris AH, Wallace CJ, Menlove RL , et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 149 (2, Pt 1): 295-305
48 Lewandowski K, Rossaint R, Pappert D , et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 1997; 23 (8) 819-835
49 Peek GJ, Mugford M, Tiruvoipati R , et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374 (9698) 1351-1363
50 Paden ML, Conrad SA, Rycus PT, Thiagarajan RR ; ELSO Registry. Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 2013; 59 (3) 202-210
51 Davies A, Jones D, Bailey M , et al; Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302 (17) 1888-1895
52 Noah MA, Peek GJ, Finney SJ , et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1). JAMA 2011; 306 (15) 1659-1668
53 Weber-Carstens S, Goldmann A, Quintel M , et al. Extracorporeal lung support in H1N1 provoked acute respiratory failure: the experience of the German ARDS Network. Dtsch Arztebl Int 2013; 110 (33–34) 543-549
54 Munshi L, Telesnicki T, Walkey A, Fan E. Extracorporeal life support for acute respiratory failure. A systematic review and metaanalysis. Ann Am Thorac Soc 2014; 11 (5) 802-810
55 Furchgott RF. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 1996; 276 (14) 1186-1188
56 Beloucif S, Payen D ; Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine. A European survey of the use of inhaled nitric oxide in the ICU. Intensive Care Med 1998; 24 (8) 864-877
57 Meade MO, Jacka MJ, Cook DJ, Dodek P, Griffith L, Guyatt GH ; Canadian Critical Care Trials Group. Survey of interventions for the prevention and treatment of acute respiratory distress syndrome. Crit Care Med 2004; 32 (4) 946-954
58 Dellinger RP, Zimmerman JL, Taylor RW , et al; Inhaled Nitric Oxide in ARDS Study Group. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998; 26 (1) 15-23
59 Taylor RW, Zimmerman JL, Dellinger RP , et al; Inhaled Nitric Oxide in ARDS Study Group. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291 (13) 1603-1609
60 Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007; 334 (7597) 779
61 Afshari A, Brok J, Møller AM, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev 2010; (7) CD002787
62 Adhikari NK, Dellinger RP, Lundin S , et al. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med 2014; 42 (2) 404-412
63 Lunkenheimer PP, Rafflenbeul W, Keller H, Frank I, Dickhut HH, Fuhrmann C. Application of transtracheal pressure oscillations as a modification of “diffusing respiration”. Br J Anaesth 1972; 44 (6) 627
64 Sud S, Sud M, Friedrich JO , et al. High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis. BMJ 2010; 340: c2327
65 Young D, Lamb SE, Shah S , et al; OSCAR Study Group. High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013; 368 (9) 806-813
66 Ferguson ND, Cook DJ, Guyatt GH , et al; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368 (9) 795-805